Fundz

Arbor Biotechnologies, Inc. reported raising $12.2 Million in an initial SEC Form D filing, from an offering of $15.6 Million

PRIVATEJun 01, 2017$12.2M of $15.6M raised

Amount Raised

$12.2 Million

$12.2 Million sold, per SEC Form D (first sale Jun 1, 2017)

Round Type

Venture

CambridgeBiotechnology

Quick answer

Arbor Biotechnologies raised $12.2 Million in a funding round, dated June 1, 2017. Arbor Biotechnologies is based in Cambridge, Massachusetts, United States.

How much did Arbor Biotechnologies raise?
Arbor Biotechnologies raised $12.2 Million in a funding round on June 1, 2017.
What does Arbor Biotechnologies do?
Arbor Bio is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry.
Where is Arbor Biotechnologies based and how big is it?
Arbor Biotechnologies is based in Cambridge, Massachusetts, United States. Fundz records about 112 employees.
Who are the decision-makers at Arbor Biotechnologies?
Fundz holds 1 contact at Arbor Biotechnologies. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Arbor Biotechnologies that raised within 45 days of this round, from Fundz verified event records.

  • Precipio, Inc. raised $400K (Seed) on July 14, 2017.
  • Rocket One raised $675K (Seed) on July 14, 2017.
  • Prima BioMed Ltd raised $5M (Seed) on July 14, 2017.
  • Akoya Biosciences raised $9M on July 14, 2017.
  • Yield10 Bioscience raised $2.3M (Seed) on July 14, 2017.
  • Precipio, Inc. raised an undisclosed amount on July 14, 2017.

Who to call at Arbor Biotechnologies, and when

A new round usually means Arbor Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arbor Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arbor Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arbor Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arbor Biotechnologies

Location

20 ACORN PARK DRIVE

Cambridge, Massachusetts, United States

About

Arbor Bio is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry. We have the unique ability to work backward from disease pathology and choose the optimal editors or combination of editors for the disease in question.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arbor Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Arbor Biotechnologies. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Arbor Biotechnologies's next move

See what Strategic adds

Arbor Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.